Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 16/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.46 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.46 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3792783 | 0.98 | KIF11 (0.50) | KIF11ALDH1A1HDAC3HDAC4HDAC1 | |
| SCHEMBL27148055 | 0.98 | KIF11 (0.50) | KIF11ALDH1A1HDAC3HDAC4HDAC1 | |
| SCHEMBL15144366 | 0.98 | KIF11 (0.50) | KIF11ALDH1A1HDAC3HDAC4HDAC1 | |
| SCHEMBL18670133 | 0.98 | KIF11 (0.50) | KIF11ALDH1A1HDAC3HDAC4HDAC1 | |
| SCHEMBL28482917 | 0.98 | KIF11 (0.50) | KIF11ALDH1A1HDAC3HDAC4HDAC1 | |
| SCHEMBL28487494 | 0.98 | KIF11 (0.50) | KIF11ALDH1A1HDAC3HDAC4HDAC1 | |
| SCHEMBL2634426 | 0.98 | KIF11 (0.50) | KIF11ALDH1A1HDAC3HDAC4HDAC1 | |
| SCHEMBL34262 | 0.98 | KIF11 (0.50) | KIF11ALDH1A1HDAC3HDAC4HDAC1 | |
| SCHEMBL329636 | 0.95 | ALDH1A1 (0.55) | KIF11ALDH1A1HDAC3HDAC4HDAC1 | |
| SCHEMBL23405872 | 0.88 | KIF11 (0.50) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220054659-A1 | PSMA-TARGETED PAMAM DENDRIMERS FOR SPECIFIC DELIVERY OF IMAGING, CONTRAST AND THERAPEUTIC AGENTS | THE JOHNS HOPKINS UNIVERSTY | 2022-02-24 | — | — | US | disclosed |
| EP-3893942-A1 | PSMA-TARGETED PAMAM DENDRIMERS FOR SPECIFIC DELIVERY OF IMAGING, CONTRAST AND THERAPEUTIC AGENTS | The Johns Hopkins University (US) | 2021-10-20 | — | — | EP | disclosed |
| EP-3733683-A1 | NUCLEOSIDE ANALOGUE, PREPARATION METHOD AND APPLICATION | GeneMind Biosciences Company Limited (CN) | 2020-11-04 | — | — | EP | disclosed |
| WO-2020123975-A1 | PSMA-TARGETED PAMAM DENDRIMERS FOR SPECIFIC DELIVERY OF IMAGING, CONTRAST AND THERAPEUTIC AGENTS | THE JOHNS HOPKINS UNIVERSITY (US) | 2020-06-18 | — | — | WO | disclosed |
| US-8653238-B2 | Compositions and methods for transport of molecules with enhanced release properties across biological barriers | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2014-02-18 | — | — | US | disclosed |
| US-8653238-B2 | Compositions and methods for transport of molecules with enhanced release properties across biological barriers | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2014-02-18 | — | — | US | disclosed |
| US-8642744-B2 | Crosslinking reagent for analysis of protein-protein interaction | AGILENT TECHNOLOGIES, INC. (US) | 2014-02-04 | — | — | US | disclosed |
| US-8642744-B2 | Crosslinking reagent for analysis of protein-protein interaction | AGILENT TECHNOLOGIES, INC. (US) | 2014-02-04 | — | — | US | disclosed |
| US-8217076-B2 | Method for preparing largazole analogs and uses thereof | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2012-07-10 | — | — | US | disclosed |
| US-20120107855-A1 | CROSSLINKING REAGENT FOR ANALYSIS OF PROTEIN-PROTEIN INTERACTION | AGILENT TECHNOLOGIES, INC. | 2012-05-03 | — | — | US | disclosed |
| US-20120107855-A1 | CROSSLINKING REAGENT FOR ANALYSIS OF PROTEIN-PROTEIN INTERACTION | AGILENT TECHNOLOGIES, INC. | 2012-05-03 | — | — | US | disclosed |
| US-20100255499-A1 | COMPOSITIONS AND METHODS FOR TRANSPORT OF MOLECULES WITH ENHANCED RELEASE PROPERTIES ACROSS BIOLOGICAL BARRIERS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-10-07 | — | — | US | disclosed |
| US-20100255499-A1 | COMPOSITIONS AND METHODS FOR TRANSPORT OF MOLECULES WITH ENHANCED RELEASE PROPERTIES ACROSS BIOLOGICAL BARRIERS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-10-07 | — | — | US | disclosed |
| US-20100255499-A1 | COMPOSITIONS AND METHODS FOR TRANSPORT OF MOLECULES WITH ENHANCED RELEASE PROPERTIES ACROSS BIOLOGICAL BARRIERS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-10-07 | — | — | US | disclosed |
| US-20100029731-A1 | Method for preparing largazole analogs and uses thereof | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2010-02-04 | — | — | US | disclosed |
| EP-1988911-A2 | COMPOSITIONS AND METHODS FOR TRANSPORT OF MOLECULES WITH ENHANCED RELEASE PROPERTIES ACROSS BIOLOGICAL BARRIERS | The Board Of Trustees Of The University Of the Leland Stanford Junior University (US) | 2008-11-12 | — | — | EP | disclosed |
| WO-2008069824-A2 | COMPOSITIONS AND METHODS FOR TRANSPORT OF MOLECULES WITH ENHANCED RELEASE PROPERTIES ACROSS BIOLOGICAL BARRIERS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2008-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029731-A1 | Method for preparing largazole analogs and uses thereof | CYP51A1, ADPRS, LPXN | KIF11 1660/4885ALDH1A1 1004/4885HDAC3 114/4885 |
| US-20120107855-A1 | CROSSLINKING REAGENT FOR ANALYSIS OF PROTEIN-PROTEIN INTERACTION | RPS27A, ECPAS, STAMBP | KIF11 2440/4885ALDH1A1 3801/4885HDAC3 2609/4885 |
| US-20220054659-A1 | PSMA-TARGETED PAMAM DENDRIMERS FOR SPECIFIC DELIVERY OF IMAGING, CONTRAST AND THERAPEUTIC AGENTS | KLK3, FOLH1, PAM | KIF11 1093/4885ALDH1A1 3202/4885HDAC3 2389/4885 |
| US-20100255499-A1 | COMPOSITIONS AND METHODS FOR TRANSPORT OF MOLECULES WITH ENHANCED RELEASE PROPERTIES ACROSS BIOLOGICAL BARRIERS | SLC2A9, SLC43A1, SLC2A8 | KIF11 840/4885ALDH1A1 1967/4885HDAC3 3252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.